Navigation Links
Primus Innovations and Health Robotics Launch Strategic Partnership to Accelerate Transformation in Chemotherapy Compounding
Date:11/12/2007

Shared vision for improving patient and staff safety and minimizing waste

of pharmaceuticals.

FRISCO, Texas, Nov. 12 /PRNewswire/ -- The convergence of a world-class sales and service organization and a manufacturing organization will allow both companies to drive new growth opportunities and ultimately transform the way cancer fighting drugs are prepared and administered. The combination of Primus Innovations, Inc. solutions, sales, and services with Health Robotics engineering, software and robotic chemotherapy compounding technology "CytoCare(TM)", will enable a new standard of precision, accuracy, safety, and price efficiencies in chemotherapy admixtures.

Jack Risenhoover, Health Robotics Managing Principal, described the trampoline effect of the combination as a "powerful tool in the battle against cancer. We are particularly pleased that Primus Innovations has selected CytoCare as its exclusive solution for chemotherapy compounding for hospitals and outpatient infusion centers. Primus' experience in outsourcing will be a significant advantage for CytoCare customers."

Steve Bohannon, Primus Innovations, Inc. CEO and President, said, "Health Robotics has designed an incredible product that tilts the scales in the battle against cancer. In CytoCare we have a rare triple win: more accurate infusions for patients, a far safer environment for pharmacists and technicians and better economics and regulatory compliance for hospitals, clinics and physicians. We are incredibly pleased to be the exclusive distributor and service provider for CytoCare in North America."

CytoCare provides unparalleled benefits for patients, staff and pharmacists. The sterile robotic environment minimizes manual interaction and the associated risk of contamination. It supports patient-specific dosing, by using the patient's unique physical profile. Thus, the medication regimen is tailored and accurate with swifter, more effective results.

Moreover, dosing accuracy is enhanced with multiple and redundant safety checks further protecting the patient from potential medication errors. There are several hundred discrete data elements of the preparation process that are automatically tracked and saved as part of the permanent electronic medical record. To address USP 797 and other regulatory standards CytoCare provides an audit trail for record keeping purposes. CytoCare generates significant, immediate savings through FTE savings, reduction of redundant components from closed transfer devices, and efficiently using partial drug vials with automated time/date stamps and beyond use expiration alerts based on user defined protocols.

Primus Innovations and Health Robotics will be showcasing the CytoCare robot at the ASHP 42nd Annual Mid Year clinical meeting and exhibition in Las Vegas December 2-6th at booth #2644.

Primus Innovations, Inc., located in Frisco, Texas is the pre-eminent provider of automation, technology and services to the Oncology Industry. Primus is a strategic business partner to its customers offering a full suite of professional services encompassing all of the elements of support and outsourcing that our customers may require allowing them to focus on their core business. Primus also provides flexible financing programs which are designed to meet their customer economic requirements. For more information please visit: http://www.primusinnovations.com

About Health Robotics:

Health Robotics is the worldwide leader in patient specific, robotic chemotherapy admixtures. Its advanced technology and innovative engineering enhances sterility, delivers accurate doses for patients and helps protect clinicians from exposure to cytotoxic agents that can occur during manual compounding. http://www.healthrobotics.net


'/>"/>
SOURCE Primus Innovations, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Access Innovations Provides Support Services for Agis Network
2. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
3. Prize for Cutting-Edge Laser Innovations
4. Health Literacy Innovations Releases New Survey on Medicaid Health Literacy Standards
5. Cleveland Clinic Unveils Top 10 Medical Innovations For 2008
6. Inverness Medical Innovations Acquires Bio-Stat Healthcare Group
7. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
8. Young Innovations, Inc. Provides Third Quarter Conference Call Details
9. Fenwal Signs Development, Distribution and Licensing Agreement With Data Innovations, Inc.
10. Young Innovations, Inc. Announces Results for the Third Quarter Ended September 30, 2007 and Declares Quarterly Dividend
11. SPOC, Inc. announces completion of $300,000 follow-on investment by Connecticut Innovations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing ... B2B Marketing. B2B Sellers will now only pay for B.A.N.T. quality sales leads based ... of IndustryArchive.Org, said, “Given the new reality that B2B buyers are controlling the sales ...
(Date:2/26/2017)... ... 2017 , ... ODH, Inc.™ announced today it will exhibit and speak ... City Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will ... Medicaid population health management. , ODH will also have an exhibit booth where attendees ...
(Date:2/26/2017)... ... 2017 , ... Occupational pesticide exposure is linked to an ... according to a study released today at the 1st Pan American Parkinson’s and ... pesticides and incidence of sporadic PD through occupational exposure. This latest study, led ...
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, expert ... Core benefits and advantages built into the home office sit stand solution are ... feel. Ability to gain the benefits embedded in the TaskMate Go are available ...
(Date:2/24/2017)... ... ... two months after the official release of The Private Collection – Edition 2017 at ... a second print-run of its lavish luxury travel coffee table book. , An ... at more than six kilos, retails at EUR 1,000 per copy and is packed ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Australien, 24. Februar 2017 ITL ... Unternehmen des Gesundheitsbereiches, ist erfreut, für das zum ... dem entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen zu können. ... Aktualisierung zum Wachstum" finden Sie hier . ... Gewinn nach Steuern 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; +104 %) ...
(Date:2/24/2017)... 2017  Directors from Pharma To Market Pty Ltd and Ador ... resulting in the founding of Pharma To Market Pte Ltd, based ... are pleased to announce their expansion into Asia ... . The company are delighted to appoint Joelle Chia ... Singapore based entity. Joelle brings with her an ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
Breaking Medicine Technology: